Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy. J. Anal. Oncol. [Internet]. 2022 Oct. 7 [cited 2026 Jun. 8];11:40-4. Available from: https://neoplasiaresearch.com/index.php/jao/article/view/682